Takeda Pharmaceutical Company Limited
Peptide compound

Abstract:

The present invention relates to a peptide compound that may be useful in the treatment or prophylaxis of obesity, diabetes and the like. More specifically, the present invention relates to a peptide compound represented by the formula (I): P.sup.1-Tyr-Aib-Glu-Gly-Thr-.alpha.-MePhe-Thr-Ser-Asp-Lys(-Gly-Gly-Gly-Gl- y-R.sup.A10)-A11-A12-Aib-Leu-A15-Lys-Gln-A18-Gln-Iva-Glu-Phe-Val-Arg-His-L- eu-Leu-Asn-Lys-Aib-Thr-Arg-Gln-Arg-A35-NH.sub.2 wherein each symbol is as defined in the specification, and the treatment or prophylaxis of obesity, diabetes and the like using the peptide compound.